Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications.

Klieser E, Mayr C, Kiesslich T, Wissniowski T, Fazio PD, Neureiter D, Ocker M.

Int J Mol Sci. 2019 Oct 23;20(21). pii: E5266. doi: 10.3390/ijms20215266. Review.

2.

NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?

Kiesslich T, Mayr C, Neureiter D.

EBioMedicine. 2019 Nov;49:9-10. doi: 10.1016/j.ebiom.2019.09.046. Epub 2019 Oct 21. No abstract available.

3.

Automated vehicle driveaway with a manual dry clutch on chassis dynamometers: Efficient identification and decoupling control.

Euler-Rolle N, Mayr CH, Škrjanc I, Jakubek S, Karer G.

ISA Trans. 2019 Aug 13. pii: S0019-0578(19)30357-X. doi: 10.1016/j.isatra.2019.08.021. [Epub ahead of print]

PMID:
31439391
4.

Acid- and Volume-Sensitive Chloride Currents in Microglial Cells.

Kittl M, Helm K, Beyreis M, Mayr C, Gaisberger M, Winklmayr M, Ritter M, Jakab M.

Int J Mol Sci. 2019 Jul 15;20(14). pii: E3475. doi: 10.3390/ijms20143475.

5.

A Biohybrid Setup for Coupling Biological and Neuromorphic Neural Networks.

Keren H, Partzsch J, Marom S, Mayr CG.

Front Neurosci. 2019 May 8;13:432. doi: 10.3389/fnins.2019.00432. eCollection 2019.

6.

Pancreatic cancer in young adults: changes, challenges, and solutions.

Primavesi F, Stättner S, Schlick K, Kiesslich T, Mayr C, Klieser E, Urbas R, Neureiter D.

Onco Targets Ther. 2019 May 6;12:3387-3400. doi: 10.2147/OTT.S176700. eCollection 2019. Review.

7.

Efficient Reward-Based Structural Plasticity on a SpiNNaker 2 Prototype.

Yan Y, Kappel D, Neumarker F, Partzsch J, Vogginger B, Hoppner S, Furber S, Maass W, Legenstein R, Mayr C.

IEEE Trans Biomed Circuits Syst. 2019 Jun;13(3):579-591. doi: 10.1109/TBCAS.2019.2906401. Epub 2019 Mar 27.

PMID:
30932847
8.

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.

Beyreis M, Gaisberger M, Jakab M, Neureiter D, Helm K, Ritter M, Kiesslich T, Mayr C.

Cancers (Basel). 2019 Feb 26;11(3). pii: E276. doi: 10.3390/cancers11030276.

9.

Memory-Efficient Deep Learning on a SpiNNaker 2 Prototype.

Liu C, Bellec G, Vogginger B, Kappel D, Partzsch J, Neumärker F, Höppner S, Maass W, Furber SB, Legenstein R, Mayr CG.

Front Neurosci. 2018 Nov 16;12:840. doi: 10.3389/fnins.2018.00840. eCollection 2018.

10.

Glycine Induces Migration of Microglial BV-2 Cells via SNAT-Mediated Cell Swelling.

Kittl M, Dobias H, Beyreis M, Kiesslich T, Mayr C, Gaisberger M, Ritter M, Kerschbaum HH, Jakab M.

Cell Physiol Biochem. 2018;50(4):1460-1473. doi: 10.1159/000494646. Epub 2018 Oct 25.

11.

Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.

Wanek J, Gaisberger M, Beyreis M, Mayr C, Helm K, Primavesi F, Jäger T, Di Fazio P, Jakab M, Wagner A, Neureiter D, Kiesslich T.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3128. doi: 10.3390/ijms19103128.

12.

Continuous, label-free, 96-well-based determination of cell migration using confluence measurement.

Mayr C, Beyreis M, Dobias H, Gaisberger M, Fuchs J, Pichler M, Ritter M, Jakab M, Helm K, Neureiter D, Kiesslich T.

Cell Adh Migr. 2019 Dec;13(1):76-82. doi: 10.1080/19336918.2018.1526612. Epub 2018 Oct 8.

13.

HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors.

Klieser E, Urbas R, Swierczynski S, Stättner S, Primavesi F, Jäger T, Mayr C, Kiesslich T, Fazio PD, Helm K, Neureiter D.

Int J Mol Sci. 2018 Sep 15;19(9). pii: E2781. doi: 10.3390/ijms19092781.

14.

Miniaturization of the Clonogenic Assay Using Confluence Measurement.

Mayr C, Beyreis M, Dobias H, Gaisberger M, Pichler M, Ritter M, Jakab M, Neureiter D, Kiesslich T.

Int J Mol Sci. 2018 Mar 3;19(3). pii: E724. doi: 10.3390/ijms19030724.

15.

Single-center implementation of endoscopic submucosal dissection (ESD) in the colorectum: Low recurrence rate after intention-to-treat ESD.

Wagner A, Neureiter D, Kiesslich T, Wolkersdörfer GW, Pleininger T, Mayr C, Dienhart C, Yahagi N, Oyama T, Berr F.

Dig Endosc. 2018 May;30(3):354-363. doi: 10.1111/den.12995. Epub 2018 Jan 3.

PMID:
29218732
16.

IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.

Kessler SM, Lederer E, Laggai S, Golob-Schwarzl N, Hosseini K, Petzold J, Schweiger C, Reihs R, Keil M, Hoffmann J, Mayr C, Kiesslich T, Pichler M, Kim KS, Rhee H, Park YN, Lax S, Obrist P, Kiemer AK, Haybaeck J.

Oncotarget. 2017 Sep 21;8(52):89736-89745. doi: 10.18632/oncotarget.21116. eCollection 2017 Oct 27.

17.

Update on the role and therapeutic potential of polycomb repressive complexes in (biliary tract) cancer.

Neureiter D, Kiesslich T, Ritter M, Mayr C.

Expert Opin Ther Targets. 2018 Jan;22(1):1-3. doi: 10.1080/14728222.2018.1406923. Epub 2017 Nov 20. No abstract available.

PMID:
29148857
18.

The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.

Mayr C, Helm K, Jakab M, Ritter M, Shrestha R, Makaju R, Wagner A, Pichler M, Beyreis M, Staettner S, Jaeger T, Klieser E, Kiesslich T, Neureiter D.

Hum Pathol. 2018 Feb;72:117-126. doi: 10.1016/j.humpath.2017.11.003. Epub 2017 Nov 11.

PMID:
29133140
19.

Biliary tract cancer stem cells - translational options and challenges.

Mayr C, Ocker M, Ritter M, Pichler M, Neureiter D, Kiesslich T.

World J Gastroenterol. 2017 Apr 14;23(14):2470-2482. doi: 10.3748/wjg.v23.i14.2470. Review.

20.

In Vitro Cell Death Discrimination and Screening Method by Simple and Cost-Effective Viability Analysis.

Helm K, Beyreis M, Mayr C, Ritter M, Jakab M, Kiesslich T, Plaetzer K.

Cell Physiol Biochem. 2017;41(3):1011-1019. doi: 10.1159/000460910. Epub 2017 Feb 21.

Supplemental Content

Loading ...
Support Center